Ingalls & Snyder LLC Novo Nordisk A S Transaction History

Ingalls & Snyder LLC

$2.56 Billion
Q3 2024

A detailed history of Ingalls & Snyder LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Ingalls & Snyder LLC holds 51,685 shares of NVO stock, worth $4.31 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

51,685

Previous 50,648 2.05%

Holding current value

$4.31 Million

Previous $7.23 Million 14.87%

% of portfolio

0.24%

Previous 0.31%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $123,475 - $150,800	1,037 Added 2.05%	51,685 $6.15 Million
Q2 2024 Jul 31, 2024	BUY	$122.71 - $146.91 $2.43 Million - $2.91 Million	19,839 Added 64.39%	50,648 $7.23 Million
Q1 2024 May 13, 2024	SELL	$102.11 - $135.92 $240,469 - $320,091	-2,355 Reduced 7.1%	30,809 $3.96 Million
Q4 2023 Jan 29, 2024	SELL	$87.78 - $105.45 $155,809 - $187,173	-1,775 Reduced 5.08%	33,164 $3.43 Million
Q3 2023 Nov 02, 2023	BUY	$90.94 - $199.54 $1.59 Million - $3.49 Million	17,471 Added 100.02%	34,939 $3.18 Million
Q3 2021 Oct 27, 2021	SELL	$84.42 - $106.62 $166,729 - $210,574	-1,975 Reduced 10.16%	17,468 $1.68 Million
Q2 2021 Aug 03, 2021	SELL	$67.66 - $84.76 $1,691 - $2,119	-25 Reduced 0.13%	19,443 $1.63 Million
Q4 2020 Jan 27, 2021	SELL	$63.89 - $73.8 $63,890 - $73,800	-1,000 Reduced 4.89%	19,468 $1.36 Million
Q3 2020 Oct 21, 2020	SELL	$63.69 - $70.22 $70,059 - $77,242	-1,100 Reduced 5.1%	20,468 $1.42 Million
Q2 2020 Jul 31, 2020	SELL	$58.54 - $67.94 $43,905 - $50,955	-750 Reduced 3.36%	21,568 $1.41 Million
Q4 2019 Jan 15, 2020	BUY	$49.86 - $58.26 $177,750 - $207,696	3,565 Added 19.01%	22,318 $1.29 Million
Q3 2019 Oct 16, 2019	SELL	$47.54 - $53.43 $23,912 - $26,875	-503 Reduced 2.61%	18,753 $970,000
Q2 2019 Jul 11, 2019	SELL	$46.79 - $52.47 $228,803 - $256,578	-4,890 Reduced 20.25%	19,256 $983,000
Q1 2019 Apr 11, 2019	SELL	$46.36 - $52.63 $1.56 Million - $1.77 Million	-33,588 Reduced 58.18%	24,146 $1.26 Million
Q4 2018 Jan 24, 2019	SELL	$41.54 - $47.25 $1.21 Million - $1.38 Million	-29,192 Reduced 33.58%	57,734 $2.66 Million
Q3 2018 Oct 24, 2018	BUY	$46.76 - $51.24 $4.06 Million - $4.45 Million	86,926 New	86,926 $4.1 Million

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $188B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.

Account

Ingalls & Snyder LLC Novo Nordisk A S Transaction History